This report aims to provide a comprehensive presentation of the global market for Chronic Urticaria Or Hives Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Urticaria Or Hives Drug. This report contains market size and forecasts of Chronic Urticaria Or Hives Drug in global, including the following market information:
Global Chronic Urticaria Or Hives Drug Market Revenue, 2018-2023, 20242035, ($ millions)
Global Chronic Urticaria Or Hives Drug Market Sales, 2018-2023, 20242035, (K Pcs)
Global top five Chronic Urticaria Or Hives Drug companies in 2022 (%)
The global Chronic Urticaria Or Hives Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
GDC-0853 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chronic Urticaria Or Hives Drug include AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited and Merck & Co., Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Urticaria Or Hives Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Urticaria Or Hives Drug Market, by Type, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, by Type, 2022 (%)
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Global Chronic Urticaria Or Hives Drug Market, by Application, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Chronic Urticaria Or Hives Drug Market, By Region and Country, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Urticaria Or Hives Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chronic Urticaria Or Hives Drug revenues share in global market, 2022 (%)
Key companies Chronic Urticaria Or Hives Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Chronic Urticaria Or Hives Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Urticaria Or Hives Drug, market overview.
Chapter 2: Global Chronic Urticaria Or Hives Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Urticaria Or Hives Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Urticaria Or Hives Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Urticaria Or Hives Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Urticaria Or Hives Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Urticaria Or Hives Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Urticaria Or Hives Drug Overall Market Size
2.1 Global Chronic Urticaria Or Hives Drug Market Size: 2022 VS 2035
2.2 Global Chronic Urticaria Or Hives Drug Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Chronic Urticaria Or Hives Drug Sales: 2018-2035
3 Company Landscape
3.1 Top Chronic Urticaria Or Hives Drug Players in Global Market
3.2 Top Global Chronic Urticaria Or Hives Drug Companies Ranked by Revenue
3.3 Global Chronic Urticaria Or Hives Drug Revenue by Companies
3.4 Global Chronic Urticaria Or Hives Drug Sales by Companies
3.5 Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Urticaria Or Hives Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Players in Global Market
3.8.1 List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Urticaria Or Hives Drug Market Size Markets, 2022 & 2035
4.1.2 GDC-0853
4.1.3 GSK-2646264
4.1.4 BF-Derm-1
4.1.5 Bilastine
4.1.6 Others
4.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
4.2.1 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2018-2023
4.2.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2024-2035
4.2.3 By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
4.3 By Type - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
4.3.1 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2018-2023
4.3.2 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2024-2035
4.3.3 By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
4.4 By Type - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Urticaria Or Hives Drug Market Size, 2022 & 2035
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
5.2.1 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2018-2023
5.2.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2024-2035
5.2.3 By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
5.3 By Application - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
5.3.1 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2018-2023
5.3.2 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2024-2035
5.3.3 By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
5.4 By Application - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Chronic Urticaria Or Hives Drug Market Size, 2022 & 2035
6.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
6.2.1 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2018-2023
6.2.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2024-2035
6.2.3 By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
6.3 By Region - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
6.3.1 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2018-2023
6.3.2 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2024-2035
6.3.3 By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Chronic Urticaria Or Hives Drug Revenue, 2018-2035
6.4.2 By Country - North America Chronic Urticaria Or Hives Drug Sales, 2018-2035
6.4.3 US Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.4.4 Canada Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.4.5 Mexico Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Chronic Urticaria Or Hives Drug Revenue, 2018-2035
6.5.2 By Country - Europe Chronic Urticaria Or Hives Drug Sales, 2018-2035
6.5.3 Germany Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5.4 France Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5.5 U.K. Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5.6 Italy Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5.7 Russia Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5.8 Nordic Countries Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.5.9 Benelux Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Chronic Urticaria Or Hives Drug Revenue, 2018-2035
6.6.2 By Region - Asia Chronic Urticaria Or Hives Drug Sales, 2018-2035
6.6.3 China Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.6.4 Japan Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.6.5 South Korea Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.6.6 Southeast Asia Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.6.7 India Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Chronic Urticaria Or Hives Drug Revenue, 2018-2035
6.7.2 By Country - South America Chronic Urticaria Or Hives Drug Sales, 2018-2035
6.7.3 Brazil Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.7.4 Argentina Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, 2018-2035
6.8.3 Turkey Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.8.4 Israel Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.8.5 Saudi Arabia Chronic Urticaria Or Hives Drug Market Size, 2018-2035
6.8.6 UAE Chronic Urticaria Or Hives Drug Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Company Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Plc Key News & Latest Developments
7.2 Biofrontera AG
7.2.1 Biofrontera AG Company Summary
7.2.2 Biofrontera AG Business Overview
7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.2.5 Biofrontera AG Key News & Latest Developments
7.3 ELORAC, Inc.
7.3.1 ELORAC, Inc. Company Summary
7.3.2 ELORAC, Inc. Business Overview
7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.3.5 ELORAC, Inc. Key News & Latest Developments
7.4 Faes Farma, SA
7.4.1 Faes Farma, SA Company Summary
7.4.2 Faes Farma, SA Business Overview
7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Major Product Offerings
7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.4.5 Faes Farma, SA Key News & Latest Developments
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Company Summary
7.5.2 Genentech, Inc. Business Overview
7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.5.5 Genentech, Inc. Key News & Latest Developments
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Company Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Plc Key News & Latest Developments
7.7 J Uriach Y Compania, S.A.
7.7.1 J Uriach Y Compania, S.A. Company Summary
7.7.2 J Uriach Y Compania, S.A. Business Overview
7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Major Product Offerings
7.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.7.5 J Uriach Y Compania, S.A. Key News & Latest Developments
7.8 Mabtech Limited
7.8.1 Mabtech Limited Company Summary
7.8.2 Mabtech Limited Business Overview
7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.8.5 Mabtech Limited Key News & Latest Developments
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Company Summary
7.9.2 Merck & Co., Inc. Business Overview
7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.9.5 Merck & Co., Inc. Key News & Latest Developments
7.10 Mycenax Biotech Inc.
7.10.1 Mycenax Biotech Inc. Company Summary
7.10.2 Mycenax Biotech Inc. Business Overview
7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.10.5 Mycenax Biotech Inc. Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Chronic Urticaria Or Hives Drug Business Overview
7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Panacea Biotec Limited
7.12.1 Panacea Biotec Limited Company Summary
7.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Business Overview
7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2018-2023)
7.12.5 Panacea Biotec Limited Key News & Latest Developments
8 Global Chronic Urticaria Or Hives Drug Production Capacity, Analysis
8.1 Global Chronic Urticaria Or Hives Drug Production Capacity, 2018-2035
8.2 Chronic Urticaria Or Hives Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Urticaria Or Hives Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Urticaria Or Hives Drug Supply Chain Analysis
10.1 Chronic Urticaria Or Hives Drug Industry Value Chain
10.2 Chronic Urticaria Or Hives Drug Upstream Market
10.3 Chronic Urticaria Or Hives Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chronic Urticaria Or Hives Drug in Global Market
Table 2. Top Chronic Urticaria Or Hives Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chronic Urticaria Or Hives Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chronic Urticaria Or Hives Drug Revenue Share by Companies, 2018-2023
Table 5. Global Chronic Urticaria Or Hives Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Chronic Urticaria Or Hives Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chronic Urticaria Or Hives Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 9. List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2024-2035
Table 16. By Application ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2024-2035
Table 21. By Region ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2024-2035
Table 26. By Country - North America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2024-2035
Table 30. By Country - Europe Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2024-2035
Table 34. By Region - Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2024-2035
Table 38. By Country - South America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2024-2035
Table 42. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2024-2035
Table 46. AstraZeneca Plc Company Summary
Table 47. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offerings
Table 48. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. AstraZeneca Plc Key News & Latest Developments
Table 50. Biofrontera AG Company Summary
Table 51. Biofrontera AG Chronic Urticaria Or Hives Drug Product Offerings
Table 52. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Biofrontera AG Key News & Latest Developments
Table 54. ELORAC, Inc. Company Summary
Table 55. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 56. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. ELORAC, Inc. Key News & Latest Developments
Table 58. Faes Farma, SA Company Summary
Table 59. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offerings
Table 60. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Faes Farma, SA Key News & Latest Developments
Table 62. Genentech, Inc. Company Summary
Table 63. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 64. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Genentech, Inc. Key News & Latest Developments
Table 66. GlaxoSmithKline Plc Company Summary
Table 67. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offerings
Table 68. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. GlaxoSmithKline Plc Key News & Latest Developments
Table 70. J Uriach Y Compania, S.A. Company Summary
Table 71. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offerings
Table 72. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. J Uriach Y Compania, S.A. Key News & Latest Developments
Table 74. Mabtech Limited Company Summary
Table 75. Mabtech Limited Chronic Urticaria Or Hives Drug Product Offerings
Table 76. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Mabtech Limited Key News & Latest Developments
Table 78. Merck & Co., Inc. Company Summary
Table 79. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 80. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Merck & Co., Inc. Key News & Latest Developments
Table 82. Mycenax Biotech Inc. Company Summary
Table 83. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 84. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Mycenax Biotech Inc. Key News & Latest Developments
Table 86. Novartis AG Company Summary
Table 87. Novartis AG Chronic Urticaria Or Hives Drug Product Offerings
Table 88. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Novartis AG Key News & Latest Developments
Table 90. Panacea Biotec Limited Company Summary
Table 91. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offerings
Table 92. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Panacea Biotec Limited Key News & Latest Developments
Table 94. Chronic Urticaria Or Hives Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 95. Global Chronic Urticaria Or Hives Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Chronic Urticaria Or Hives Drug Production by Region, 2018-2023 (K Pcs)
Table 97. Global Chronic Urticaria Or Hives Drug Production by Region, 2024-2035 (K Pcs)
Table 98. Chronic Urticaria Or Hives Drug Market Opportunities & Trends in Global Market
Table 99. Chronic Urticaria Or Hives Drug Market Drivers in Global Market
Table 100. Chronic Urticaria Or Hives Drug Market Restraints in Global Market
Table 101. Chronic Urticaria Or Hives Drug Raw Materials
Table 102. Chronic Urticaria Or Hives Drug Raw Materials Suppliers in Global Market
Table 103. Typical Chronic Urticaria Or Hives Drug Downstream
Table 104. Chronic Urticaria Or Hives Drug Downstream Clients in Global Market
Table 105. Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Segment by Type in 2022
Figure 2. Chronic Urticaria Or Hives Drug Segment by Application in 2022
Figure 3. Global Chronic Urticaria Or Hives Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Urticaria Or Hives Drug Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Chronic Urticaria Or Hives Drug Revenue, 2018-2035 (US$, Mn)
Figure 7. Chronic Urticaria Or Hives Drug Sales in Global Market: 2018-2035 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Urticaria Or Hives Drug Revenue in 2022
Figure 9. By Type - Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 11. By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 12. By Type - Global Chronic Urticaria Or Hives Drug Price (USD/Pcs), 2018-2035
Figure 13. By Application - Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 15. By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 16. By Application - Global Chronic Urticaria Or Hives Drug Price (USD/Pcs), 2018-2035
Figure 17. By Region - Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 20. By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 21. By Country - North America Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 22. By Country - North America Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 23. US Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 28. Germany Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 29. France Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 37. China Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 41. India Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 43. By Country - South America Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 44. Brazil Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share, 2018-2035
Figure 48. Turkey Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2018-2035
Figure 52. Global Chronic Urticaria Or Hives Drug Production Capacity (K Pcs), 2018-2035
Figure 53. The Percentage of Production Chronic Urticaria Or Hives Drug by Region, 2022 VS 2035
Figure 54. Chronic Urticaria Or Hives Drug Industry Value Chain
Figure 55. Marketing Channels
